|
Orthologous residues
|
|
ITK (human): Y512‑p, ITK (mouse): Y517‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
Jurkat (T lymphocyte), SF9, T lymphocyte-blood
|
|
Cellular systems studied:
cell lines, primary cultured cells
|
|
Species studied:
human, insect, mouse
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
Lck (mouse)
|
genetic transfer of wild-type enzyme, phospho-antibody
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
anti-CD3
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
enzymatic activity, induced, phosphorylation
|
|
Comments:
stimulates phosphorylation of ITK Y186
|